Sodium butyrate alleviates experimental autoimmune prostatitis by inhibiting oxidative stress and NLRP3 inflammasome activation via the Nrf2/HO‐1 pathway

Ähnliche Einträge

• The role of gut microbiota involved in prostate microenvironment and symptoms improvement in chronic prostatitis/chronic pelvic pain syndrome patients treated with low‐intensity extracorporeal shock wave
  von: Xiangbin Kong, et al.
  Veröffentlicht: (2024)
• Co‐targeting SKP2 and KDM5B inhibits prostate cancer progression by abrogating AKT signaling with induction of senescence and apoptosis
  von: LaKendria K. Brown, et al.
  Veröffentlicht: (2024)
• PIK3/Akt/mTOR pathway alterations in metastatic castration‐sensitive prostate cancer
  von: Philip Sutera, et al.
  Veröffentlicht: (2024)
• Performance of large language models on benign prostatic hyperplasia frequently asked questions
  von: YuNing Zhang, et al.
  Veröffentlicht: (2024)
• Cumulative cancer locations on prostate biopsy and active surveillance outcomes in the MRI era
  von: Sean A. Fletcher, et al.
  Veröffentlicht: (2024)